BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2185315)

  • 1. Isolation and characterization of circulating immune complexes from rats with experimental membranous nephropathy.
    Hori MT; Abrass CK
    J Immunol; 1990 May; 144(10):3849-55. PubMed ID: 2185315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of sequential glomerular eluates from rats with Heymann nephritis.
    Abrass CK
    J Immunol; 1986 Jul; 137(2):530-5. PubMed ID: 3487574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of glomerular localization of subepithelial immune deposits: effects of altered antigen to antibody ratio, steroids, vasoactive amine antagonists, and aminonucleoside of puromycin on passive Heymann nephritis in rats.
    Salant DJ; Belok S; Stilmant MM; Darby C; Couser WG
    Lab Invest; 1979 Jul; 41(1):89-99. PubMed ID: 376941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of antibodies with human glomerular epithelial cells.
    Fukatsu A; Yuzawa Y; Olson L; Miller J; Milgrom M; Zamlauski-Tucker MJ; Van Liew JB; Campagnari A; Niesen N; Patel J
    Lab Invest; 1989 Oct; 61(4):389-403. PubMed ID: 2796288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The immune complex pathogenesis of experimental membranous glomerulopathy (Heymann nephritis) and its significance in human glomerular disease].
    Kerjaschki D
    Verh Dtsch Ges Pathol; 1989; 73():24-35. PubMed ID: 2482609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic targets in epimembranous glomerulonephritis. Experimental data and potential application in human pathology.
    Ronco P; Allegri L; Brianti E; Chatelet F; Van Leer EH; Verroust P
    Appl Pathol; 1989; 7(2):85-98. PubMed ID: 2567175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M; Schulze M; Exner M; Kerjaschki D
    Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous immune complex nephropathy associated with malignancy I. Studies on the nature and immunopathogenic significance of glomerular bound antigen and antibody, isolation and characterization of tumor specific antigen and antibody and circulating immune complexes.
    Ozawa T; Pluss R; Lacher J; Boedecker E; Guggenheim S; Hammond W; McIntosh R
    Q J Med; 1975 Oct; 44(176):523-41. PubMed ID: 53850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of an antigen distinct from the Heymann antigen in membranous glomerulonephritis in the mouse.
    Assmann KJ; Ronco P; Tangelder MM; Lange WP; Verroust P; Koene RA
    Lab Invest; 1989 Jan; 60(1):138-46. PubMed ID: 2642986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
    Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G
    J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on the pathogenic roles of antigens isolated from renal tubular cells in the classical Heymann nephritis].
    Yamagata K; Koyama A; Kobayashi M; Narita M
    Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1053-60. PubMed ID: 2287097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunopathogenesis of membranous nephropathy.
    Oliveira DB
    Minerva Med; 2002 Oct; 93(5):323-8. PubMed ID: 12410164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies with monoclonal antibodies against brush border antigens in Heymann nephritis.
    Bhan AK; Schneeberger EE; Baird LG; Collins AB; Kamata K; Bradford D; Erikson ME; McCluskey RT
    Lab Invest; 1985 Oct; 53(4):421-32. PubMed ID: 3900581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Etiopathogenesis of membranous nephropathy: is there a correlation between experimental and human pathology?].
    Allegri L; Celendo MT; Savazzi G; Garini G; Carnevali ML
    Ann Ital Med Int; 1989; 4(4):386-95. PubMed ID: 2487793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating immune complexes in rats with autologous immune complex nephritis.
    Abrass CK; Border WA; Glassock RJ
    Lab Invest; 1980 Jul; 43(1):18-27. PubMed ID: 6446622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
    Makker SP; Tramontano A
    J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive Heymann nephritis with acute and severe proteinuria induced by heterologous antibody against renal tubular brush border glycoprotein gp108.
    Natori Y; Hayakawa I; Shibata S
    Lab Invest; 1986 Jul; 55(1):63-70. PubMed ID: 3755192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous immune complex nephritis in rats. Influence of modification of mononuclear phagocyte system function.
    Abrass CK
    Lab Invest; 1984 Aug; 51(2):162-71. PubMed ID: 6611451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic fate of monovalent and multivalent antibodies of Heymann nephritis following formation of surface immune complexes on glomerular epithelial cells.
    Singh AK; Kasinath BS
    Clin Exp Immunol; 1993 Dec; 94(3):403-11. PubMed ID: 8252800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparative polyacrylamide gel electrophoresis in the isolation of the nephritogenic proteins of passive Heymann nephritis.
    Miettinen A; Törnroth T; Vartio T
    APMIS; 1989 Jun; 97(6):479-89. PubMed ID: 2660856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.